Introduction N ck is a ubiquitous SH2/SH3 adaptor protein that acts as a scaffold, connecting receptor tyrosine kinases in the plasma membrane with cytoplasmic signaling proteins involved in rearrangement of the actin cytoskeleton. Therefore, Nck is an important player in actin-guided axonal growth in neurons and in kidney podocyte mobility [1] . However, Nck also mediates the activation of signaling pathways that directly result in transcriptional regulation of gene expression. Indeed, proteins recruited by Nck may activate JNK and ERK MAPK pathways, as well as Rac1/Cdc42 pathways [2] . In B cells, Nck has been associated with PI3K pathway activation by binding and recruiting the adaptor protein BCAP to a phosphorylated tyrosine in the Iga subunit of the BCR [3] . Antigen-induced binding of Nck to phospho-Iga depends on the SH2 domain of Nck. In contrast, in the context of T cells, Nck is recruited to a unique, proline-rich sequence in the cytoplasmic domain of the CD3e subunit of the TCR, which is absent in other TCR subunits and the BCR [4, 5] (Fig. 1) .
The mechanistic differences between Nck recruitment to BCRs vs. TCRs described above highlight a nick in TCR signaling models. What molecular entity could be playing the part of BCAP in T cells potentially to mediate TCR-driven PI3K activation through Nck? This question indeed hinges on the assumption that similar to its behavior in B cells, Nck must also participate in the activation of the PI3K/Akt pathway in T cells. In a recent paper, published in this issue of the Journal of Leukocyte Biology, Lu et al. [6] Tfh. Nck has indeed been found essential for T cell proliferation in response to weak antigens, i.e., antigens with low affinity for the TCR, but not in response to strong antigens [7] . Interestingly, this behavior correlated with a previous study, in T cells bearing a mutation in the proline-rich sequence of CD3e, which therefore, are unable to recruit Nck to the TCR. This mutation also gave rise to defective proliferation in response to weak, although not to strong, antigens [8] , suggesting that Nck is placed immediately downstream of the TCR in response to weak antigens. As the authors discuss, this differential participation in weak vs. strong antigen TCR signaling places the spotlight on Nck as a target for the treatment of autoimmune diseases, such as lupus erythematosus, which involves the production of antibodies against autoantigens [9] . Previous studies described that strong and weak antigens also differentially promote CD4 T cell differentiation to Th1 or Tfh [10] . Therefore, it would have been highly consistent with preexisting data to establish a correlation between the differential requirement of Nck for T cell activation by weak vs. strong antigens and CD4 T cell differentiation into [11, 12] , and of costimulatory receptors, such as ICOS. Indeed, the transcription factor forkhead box protein O1, a PI3K/Akt effector, must first become inactivated by ICOS signaling to allow initial Tfh differentiation, although it requires activation at a later stage to reach complete germinal center Tfh differentiation [13] . Hence, Nck deficiency in T cells from Nck.T ─/─ mice does not provide direct clues concerning the nature of the receptors involved in PI3K signaling. Therefore, the results of Lu et al. [6] leave the possibility open for considering Nck as a signaling coordinator that acts through multiple membrane receptors, ultimately resulting in activation of the PI3K pathway in B cells and T cells. [6] indicate that Nck plays an important role in Tfh cell survival by a PI3K-dependent mechanism. However, the identity of the membrane receptor that activates this pathway is still unknown. The TCR is a known candidate, although costimulatory receptors that activate the PI3K pathway and therefore, are important for Tfh differentiation and survival, such as ICOS, might potentially direct the pathway.
